Reuters logo
BRIEF-Auxilium expects to submit supplemental biologics license application for Xiaflex to FDA in Q1
November 18, 2013 / 12:30 PM / 4 years ago

BRIEF-Auxilium expects to submit supplemental biologics license application for Xiaflex to FDA in Q1

Nov 18 (Reuters) - Auxilium Pharmaceuticals Inc : * Announces results of the xiaflex in dupuytren’s multicord contracture trial * Says expects to submit supplemental biologics license application to FDA in

Q1 of 2014 on xiaflex * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below